Pernock David

Avg. Two Year Performance

(43%) Avg. Purchase Return
(20%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return8%10%(9%)(19%)(43%)
Purchase Success Rate5 of 94 of 92 of 92 of 91 of 9
Average Sale Return----------
Sale Success Rate----------
Drugs » Drugs - Generic

Chairman and CEO, Director:

Holdings: 105.6K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drugs - Generic

Pres & Chief Operating Officer:

Holdings: 54.63K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--